Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/ranbaxy-drugs-safe-says-australian-drug-regulator-21794/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/ranbaxy-drugs-safe-says-australian-drug-regulator-21794/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/ranbaxy-drugs-safe-says-australian-drug-regulator-21794/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/ranbaxy-drugs-safe-says-australian-drug-regulator-21794/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-trace').style.display = (document.getElementById('cakeErr67fe7e3c5a733-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fe7e3c5a733-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-code').style.display = (document.getElementById('cakeErr67fe7e3c5a733-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-context').style.display = (document.getElementById('cakeErr67fe7e3c5a733-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fe7e3c5a733-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fe7e3c5a733-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21647,
		&#039;title&#039; =&gt; &#039;Ranbaxy drugs safe says Australian drug regulator&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
 &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The company has already closed down the Gloversville facility.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;ranbaxy-drugs-safe-says-australian-drug-regulator-21794&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21794,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21647,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Ranbaxy,Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&amp;quot;At present, there is no evidence that any of the products in the Australian market...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt; &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The company has already closed down the Gloversville facility.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21647,
	&#039;title&#039; =&gt; &#039;Ranbaxy drugs safe says Australian drug regulator&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
 &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The company has already closed down the Gloversville facility.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;ranbaxy-drugs-safe-says-australian-drug-regulator-21794&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21794,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21647
$metaTitle = &#039;LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator&#039;
$metaKeywords = &#039;Ranbaxy,Health,medicines&#039;
$metaDesc = &#039;
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&amp;quot;At present, there is no evidence that any of the products in the Australian market...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt; &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The company has already closed down the Gloversville facility.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ranbaxy-drugs-safe-says-australian-drug-regulator-21794.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator | Im4change.org</title>
    <meta name="description" content="
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&quot;At present, there is no evidence that any of the products in the Australian market..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Ranbaxy drugs safe says Australian drug regulator</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times</div><p align="justify"><br /> <em>NEW DELHI: </em>After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.</p><p align="justify">&quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.</p><p align="justify">The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.</p><p align="justify">The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.</p><p align="justify">&quot;The conclusion at the time was that there was no cause for concern for products in those markets,&quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.</p><p align="justify">On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US.</p><p align="justify">The company has already closed down the Gloversville facility.</p><p align="justify">Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.</p><p align="justify">The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.</p><p align="justify">In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-trace').style.display = (document.getElementById('cakeErr67fe7e3c5a733-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fe7e3c5a733-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-code').style.display = (document.getElementById('cakeErr67fe7e3c5a733-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-context').style.display = (document.getElementById('cakeErr67fe7e3c5a733-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fe7e3c5a733-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fe7e3c5a733-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21647,
		&#039;title&#039; =&gt; &#039;Ranbaxy drugs safe says Australian drug regulator&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
 &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The company has already closed down the Gloversville facility.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;ranbaxy-drugs-safe-says-australian-drug-regulator-21794&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21794,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21647,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Ranbaxy,Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&amp;quot;At present, there is no evidence that any of the products in the Australian market...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt; &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The company has already closed down the Gloversville facility.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21647,
	&#039;title&#039; =&gt; &#039;Ranbaxy drugs safe says Australian drug regulator&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
 &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The company has already closed down the Gloversville facility.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;ranbaxy-drugs-safe-says-australian-drug-regulator-21794&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21794,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21647
$metaTitle = &#039;LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator&#039;
$metaKeywords = &#039;Ranbaxy,Health,medicines&#039;
$metaDesc = &#039;
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&amp;quot;At present, there is no evidence that any of the products in the Australian market...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt; &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The company has already closed down the Gloversville facility.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ranbaxy-drugs-safe-says-australian-drug-regulator-21794.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator | Im4change.org</title>
    <meta name="description" content="
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&quot;At present, there is no evidence that any of the products in the Australian market..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Ranbaxy drugs safe says Australian drug regulator</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times</div><p align="justify"><br /> <em>NEW DELHI: </em>After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.</p><p align="justify">&quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.</p><p align="justify">The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.</p><p align="justify">The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.</p><p align="justify">&quot;The conclusion at the time was that there was no cause for concern for products in those markets,&quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.</p><p align="justify">On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US.</p><p align="justify">The company has already closed down the Gloversville facility.</p><p align="justify">Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.</p><p align="justify">The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.</p><p align="justify">In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-trace').style.display = (document.getElementById('cakeErr67fe7e3c5a733-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fe7e3c5a733-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-code').style.display = (document.getElementById('cakeErr67fe7e3c5a733-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7e3c5a733-context').style.display = (document.getElementById('cakeErr67fe7e3c5a733-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fe7e3c5a733-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fe7e3c5a733-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21647,
		&#039;title&#039; =&gt; &#039;Ranbaxy drugs safe says Australian drug regulator&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
 &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The company has already closed down the Gloversville facility.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;ranbaxy-drugs-safe-says-australian-drug-regulator-21794&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21794,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21647,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Ranbaxy,Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&amp;quot;At present, there is no evidence that any of the products in the Australian market...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt; &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The company has already closed down the Gloversville facility.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21647,
	&#039;title&#039; =&gt; &#039;Ranbaxy drugs safe says Australian drug regulator&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
 &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The company has already closed down the Gloversville facility.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;ranbaxy-drugs-safe-says-australian-drug-regulator-21794&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21794,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21647
$metaTitle = &#039;LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator&#039;
$metaKeywords = &#039;Ranbaxy,Health,medicines&#039;
$metaDesc = &#039;
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&amp;quot;At present, there is no evidence that any of the products in the Australian market...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt; &lt;em&gt;NEW DELHI: &lt;/em&gt;After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&amp;quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company&#039;s settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The conclusion at the time was that there was no cause for concern for products in those markets,&amp;quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company&#039;s Gloversville facility in the US.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The company has already closed down the Gloversville facility.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Last week, on Monday, the company&#039;s share price had dropped by 7% after reports that Ranbaxy&#039;s newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it&#039;s reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that &#039;no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality&#039;.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ranbaxy-drugs-safe-says-australian-drug-regulator-21794.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator | Im4change.org</title>
    <meta name="description" content="
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&quot;At present, there is no evidence that any of the products in the Australian market..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Ranbaxy drugs safe says Australian drug regulator</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Economic Times</div><p align="justify"><br /> <em>NEW DELHI: </em>After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.</p><p align="justify">&quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.</p><p align="justify">The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.</p><p align="justify">The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.</p><p align="justify">&quot;The conclusion at the time was that there was no cause for concern for products in those markets,&quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.</p><p align="justify">On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US.</p><p align="justify">The company has already closed down the Gloversville facility.</p><p align="justify">Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.</p><p align="justify">The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.</p><p align="justify">In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 21647,
		'title' => 'Ranbaxy drugs safe says Australian drug regulator',
		'subheading' => '',
		'description' => '<div align="justify">
-The Economic Times
</div>
<p align="justify">
<br />
 <em>NEW DELHI: </em>After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
</p>
<p align="justify">
&quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
</p>
<p align="justify">
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
</p>
<p align="justify">
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
</p>
<p align="justify">
&quot;The conclusion at the time was that there was no cause for concern for products in those markets,&quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
</p>
<p align="justify">
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US.
</p>
<p align="justify">
The company has already closed down the Gloversville facility.
</p>
<p align="justify">
Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
</p>
<p align="justify">
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
</p>
<p align="justify">
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.
</p>',
		'credit_writer' => 'The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'ranbaxy-drugs-safe-says-australian-drug-regulator-21794',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 21794,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 21647,
	'metaTitle' => 'LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator',
	'metaKeywords' => 'Ranbaxy,Health,medicines',
	'metaDesc' => '
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&quot;At present, there is no evidence that any of the products in the Australian market...',
	'disp' => '<div align="justify">-The Economic Times</div><p align="justify"><br /> <em>NEW DELHI: </em>After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.</p><p align="justify">&quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.</p><p align="justify">The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.</p><p align="justify">The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.</p><p align="justify">&quot;The conclusion at the time was that there was no cause for concern for products in those markets,&quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.</p><p align="justify">On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US.</p><p align="justify">The company has already closed down the Gloversville facility.</p><p align="justify">Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.</p><p align="justify">The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.</p><p align="justify">In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 21647,
	'title' => 'Ranbaxy drugs safe says Australian drug regulator',
	'subheading' => '',
	'description' => '<div align="justify">
-The Economic Times
</div>
<p align="justify">
<br />
 <em>NEW DELHI: </em>After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.
</p>
<p align="justify">
&quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.
</p>
<p align="justify">
The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.
</p>
<p align="justify">
The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.
</p>
<p align="justify">
&quot;The conclusion at the time was that there was no cause for concern for products in those markets,&quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.
</p>
<p align="justify">
On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US.
</p>
<p align="justify">
The company has already closed down the Gloversville facility.
</p>
<p align="justify">
Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.
</p>
<p align="justify">
The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.
</p>
<p align="justify">
In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.
</p>',
	'credit_writer' => 'The Economic Times, 3 July, 2013, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-drugs-safe-says-australian-drug-regulator/articleshow/20884068.cm',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'ranbaxy-drugs-safe-says-australian-drug-regulator-21794',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 21794,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 21647
$metaTitle = 'LATEST NEWS UPDATES | Ranbaxy drugs safe says Australian drug regulator'
$metaKeywords = 'Ranbaxy,Health,medicines'
$metaDesc = '
-The Economic Times



 NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.


&quot;At present, there is no evidence that any of the products in the Australian market...'
$disp = '<div align="justify">-The Economic Times</div><p align="justify"><br /> <em>NEW DELHI: </em>After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe.</p><p align="justify">&quot;At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia,&quot; a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET.</p><p align="justify">The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty.</p><p align="justify">The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters.</p><p align="justify">&quot;The conclusion at the time was that there was no cause for concern for products in those markets,&quot; he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers.</p><p align="justify">On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US.</p><p align="justify">The company has already closed down the Gloversville facility.</p><p align="justify">Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations.</p><p align="justify">The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same.</p><p align="justify">In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Ranbaxy drugs safe says Australian drug regulator

-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian Therapeutic Goods Administration is aware of the criminal settlement involving Ranbaxy, said the spokesperson about the company's settlement in US with department of Justice where it pleaded guilty and agreed to pay $500 million penalty. The spokesperson further said that the Australian drug regulator was part of a multilateral inspection team involving the World Health Organisation and inspectors from the United Kingdom, Ireland, Germany, Canada and Singapore in 2008 to investigate these matters. "The conclusion at the time was that there was no cause for concern for products in those markets," he added. Besides, the TGA also independently tested samples of Ranbaxy products and found nothing to suggest unacceptable quality or a danger to consumers. On Tuesday, Ranbaxy stock rallied 6.5% after reports that the US Food and Drug Administration said there was no evidence of major current good manufacturing practices (cGMP) violations except at the company's Gloversville facility in the US. The company has already closed down the Gloversville facility. Last week, on Monday, the company's share price had dropped by 7% after reports that Ranbaxy's newly-commissioned facility at Mohali plant is under US FDA scanner for cGMP deviations. The UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has recently said that it's reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same. In the same statement, the British regulator acknowledged that despite several focused inspections in collaboration with multiple drug regulators since 2006, it has found that the company complied in general with EU good manufacturing practice (GMP). It also added that 'no evidence that any of the products on the UK market manufactured by Ranbaxy are or have been of unacceptable quality'.